Biaxin: Potent Macrolide Antibiotic for Bacterial Infection Resolution
| Product dosage: 250mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $3.60 | $107.91 (0%) | 🛒 Add to cart |
| 60 | $2.87 | $215.82 $172.45 (20%) | 🛒 Add to cart |
| 90 | $2.62 | $323.73 $235.99 (27%) | 🛒 Add to cart |
| 120 | $2.50 | $431.64 $300.53 (30%) | 🛒 Add to cart |
| 180 | $2.39
Best per pill | $647.46 $430.63 (33%) | 🛒 Add to cart |
Biaxin (clarithromycin) is a semi-synthetic macrolide antibiotic indicated for the treatment of a wide spectrum of bacterial infections. It functions by inhibiting protein synthesis in susceptible bacteria, leading to bacteriostatic action. This medication is commonly prescribed for respiratory tract infections, skin and soft tissue infections, and Helicobacter pylori eradication regimens. Its well-established pharmacokinetic profile includes good tissue penetration and bioavailability, making it a reliable choice for clinicians in both community and hospital settings.
Features
- Active pharmaceutical ingredient: Clarithromycin
- Available in oral formulations: tablets (250 mg, 500 mg) and granules for suspension
- Extended-spectrum macrolide antibiotic with activity against Gram-positive and some Gram-negative organisms
- Acid-stable formulation allowing for administration without regard to meals
- Twice-daily dosing regimen for most indications
- FDA-approved for both adult and pediatric populations (age 6 months and older)
Benefits
- Effectively treats common community-acquired respiratory infections including pneumonia, bronchitis, and sinusitis
- Demonstrated efficacy in eradicating Helicobacter pylori when used in combination therapy, reducing ulcer recurrence
- Provides coverage against atypical pathogens including Mycoplasma pneumoniae and Legionella pneumophila
- Offers convenient twice-daily dosing that supports patient adherence to treatment regimens
- Generally well-tolerated profile with established safety data across multiple patient populations
- Available in both tablet and suspension forms to accommodate different patient needs and preferences
Common use
Biaxin is primarily prescribed for bacterial infections caused by susceptible organisms. Common indications include acute exacerbation of chronic bronchitis, community-acquired pneumonia, pharyngitis, tonsillitis, acute maxillary sinusitis, and uncomplicated skin and soft tissue infections. It is also used as part of combination therapy for the eradication of Helicobacter pylori to reduce the risk of duodenal ulcer recurrence. Off-label uses may include treatment of certain mycobacterial infections, particularly Mycobacterium avium complex (MAC) in HIV patients, though this requires careful medical supervision.
Dosage and direction
The dosage of Biaxin varies based on the infection being treated, renal function, and patient factors. For most respiratory infections in adults, the typical dose is 250-500 mg twice daily for 7-14 days. For Helicobacter pylori eradication, clarithromycin 500 mg twice daily is combined with other antibiotics and acid suppressants for 10-14 days. Pediatric dosing is based on body weight at 7.5 mg/kg twice daily, not to exceed adult doses. Tablets should be swallowed whole with water; the suspension should be shaken well before use. Administration may occur with or without food, though taking with food may minimize gastrointestinal discomfort.
Precautions
Patients should complete the full prescribed course of therapy even if symptoms improve to prevent antibiotic resistance. Use with caution in patients with renal impairment (creatinine clearance less than 30 mL/min); dosage adjustment is recommended. Hepatic function should be monitored during prolonged therapy. May cause exacerbation of symptoms in patients with myasthenia gravis. Prolonged use may result in fungal or bacterial superinfection, including pseudomembranous colitis. Patients should be advised that diarrhea during or after antibiotic treatment could indicate Clostridium difficile-associated diarrhea.
Contraindications
Biaxin is contraindicated in patients with known hypersensitivity to clarithromycin, other macrolide antibiotics, or any component of the formulation. Concomitant administration with cisapride, pimozide, astemizole, terfenadine, ergotamine, or dihydroergotamine is contraindicated due to potential for serious cardiac adverse events. Should not be used in patients with history of cholestatic jaundice/hepatic dysfunction associated with prior clarithromycin use. Contraindicated in patients with known QT prolongation or ventricular arrhythmias, including torsades de pointes.
Possible side effect
Common adverse reactions (≥1%) include diarrhea, nausea, abnormal taste, dyspepsia, abdominal pain, and headache. Less frequently reported effects include vomiting, glossitis, stomatitis, oral moniliasis, and transient elevations in liver enzymes. Serious but rare side effects include QT prolongation, ventricular arrhythmias, hepatitis, Stevens-Johnson syndrome, and Clostridium difficile-associated diarrhea. Hearing loss, usually reversible, has been reported predominantly in elderly women and those with renal impairment. Patients should report any signs of allergic reaction, severe diarrhea, irregular heartbeat, or hearing changes.
Drug interaction
Biaxin has significant drug interaction potential due to its metabolism via CYP3A4 and inhibition of this enzyme. Concurrent use with colchicine may lead to life-threatening toxicity. Increases concentrations of many drugs including statins (particularly simvastatin and lovastatin), calcium channel blockers, sildenafil, and anticoagulants. Potentially serious interactions occur with drugs that prolong QT interval including antiarrhythmics, antipsychotics, and certain antidepressants. May reduce effectiveness of oral contraceptives; additional contraceptive methods recommended. Interactions with antacids containing aluminum or magnesium may reduce absorption.
Missed dose
If a dose is missed, it should be taken as soon as remembered unless it is almost time for the next scheduled dose. In that case, skip the missed dose and resume the regular dosing schedule. Do not double the dose to make up for a missed one. Maintaining consistent antibiotic levels is important for efficacy, so patients should try to adhere to the prescribed dosing schedule. Setting reminders or using pill organizers can help maintain consistent dosing intervals.
Overdose
Symptoms of overdose may include severe nausea, vomiting, diarrhea, and abdominal pain. In severe cases, reversible hearing loss, QT prolongation, and hepatic dysfunction may occur. Management is supportive with monitoring of electrolyte balance, cardiac function, and hepatic parameters. Gastric lavage may be considered if presentation is immediate. Hemodialysis does not significantly remove clarithromycin from circulation. Medical attention should be sought immediately for suspected overdose, particularly in patients with pre-existing cardiac conditions.
Storage
Store at room temperature (20-25°C or 68-77°F) in the original container. Protect from light and excessive moisture. Keep the bottle tightly closed. Do not store in bathroom areas where moisture levels fluctuate. Keep out of reach of children and pets. The suspension form should not be refrigerated and should be discarded after 14 days once reconstituted. Do not use beyond the expiration date printed on packaging.
Disclaimer
This information is for educational purposes only and does not constitute medical advice. Biaxin is a prescription medication that should only be used under the supervision of a qualified healthcare professional. Dosage and treatment duration must be determined by a physician based on individual patient factors. Patients should not self-medicate or adjust dosing without medical consultation. The complete prescribing information should be reviewed before initiation of therapy.
Reviews
Clinical studies demonstrate Biaxin’s efficacy with cure rates of 85-95% for respiratory infections when caused by susceptible organisms. Physicians report reliable performance in community practice, particularly for respiratory infections and H. pylori eradication. Patient reviews frequently mention effectiveness in resolving infections but note gastrointestinal side effects as the most common drawback. The twice-daily dosing is generally viewed as convenient compared to more frequent dosing regimens. Some patients report metallic taste as a bothersome but manageable side effect.